NeoGenomics Completes Acquisition of Pathline
NeoGenomics is committed to the advancement of cancer care. We work with institutions and thought leaders to continually innovate and develop more impactful diagnostic, therapy selection, and MRD tests.
Our Client Services team is on hand to help. Please call us at 866.776.5907, Option 3.
